140 related articles for article (PubMed ID: 24408089)
21. The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study.
Hoyer JD; Hanson CA; Fonseca R; Greipp PR; Dewald GW; Kurtin PJ
Am J Clin Pathol; 2000 Jun; 113(6):831-7. PubMed ID: 10874884
[TBL] [Abstract][Full Text] [Related]
22. Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis.
Saini N; Ma J; Milton DR; Patel R; Varma A; Bashir Q; Delgado R; Mukherjee A; Rondon G; Popat UR; Hosing CM; Nieto Y; Kebriaei P; Alousi AM; Ahmed S; Tang G; Mehta R; Srour S; Khouri IF; Iyer S; Weber DM; Thomas SK; Lee HC; Manasanch EE; Patel KK; Orlowski RZ; Champlin RE; Qazilbash MH
Clin Cancer Res; 2019 Nov; 25(22):6781-6787. PubMed ID: 31481508
[TBL] [Abstract][Full Text] [Related]
23. Cyclin D1 expression in patients with multiple myeloma.
Troussard X; Avet-Loiseau H; Macro M; Mellerin MP; Malet M; Roussel M; Sola B
Hematol J; 2000; 1(3):181-5. PubMed ID: 11920187
[TBL] [Abstract][Full Text] [Related]
24. Translocation t(4;14) retains prognostic significance even in the setting of high-risk molecular signature.
Chng WJ; Kuehl WM; Bergsagel PL; Fonseca R
Leukemia; 2008 Feb; 22(2):459-61. PubMed ID: 17805328
[No Abstract] [Full Text] [Related]
25. Overexpression of the PRAD1 oncogene in a patient with multiple myeloma and t(11;14)(q13;q32).
Kobayashi H; Saito H; Kitano K; Kiyosawa K; Gaun S; Aoki K; Narita A; Watanabe M; Uchimaru K; Motokura T
Acta Haematol; 1995; 94(4):199-203. PubMed ID: 8610478
[TBL] [Abstract][Full Text] [Related]
26. t(11;14) multiple myeloma: a subtype associated with distinct immunological features, immunophenotypic characteristics but divergent outcome.
An G; Xu Y; Shi L; Zou D; Deng S; Sui W; Xie Z; Hao M; Chang H; Qiu L
Leuk Res; 2013 Oct; 37(10):1251-7. PubMed ID: 23927993
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D1 as the putative bcl-1 oncogene.
Harris AW; Bodrug SE; Warner BJ; Bath ML; Lindeman GJ; Adams JM
Curr Top Microbiol Immunol; 1995; 194():347-53. PubMed ID: 7895508
[No Abstract] [Full Text] [Related]
28. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32).
Louie DC; Offit K; Jaslow R; Parsa NZ; Murty VV; Schluger A; Chaganti RS
Blood; 1995 Oct; 86(8):2892-9. PubMed ID: 7579380
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14).
Pruneri G; Fabris S; Baldini L; Carboni N; Zagano S; Colombi MA; Ciceri G; Lombardi L; Rocchi M; Buffa R; Maiolo AT; Neri A
Am J Pathol; 2000 May; 156(5):1505-13. PubMed ID: 10793062
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 positive multiple myeloma: predominance of the short, 3'UTR-deficient transcript is associated with high cyclin D1 mRNA levels in cases with t(11;14) translocation, but does not correlate with proliferation rate or genomic deletions.
Slotta-Huspenina J; Koch I; Richter M; Bink K; Kremer M; Specht K; Krugmann J; Quintanilla-Martinez L; Fend F
Leuk Res; 2008 Jan; 32(1):79-88. PubMed ID: 17629555
[TBL] [Abstract][Full Text] [Related]
31. t(11;14) does not predict long-term survival in myeloma.
Chang H; Qi XY; Stewart AK
Leukemia; 2005 Jun; 19(6):1078-9. PubMed ID: 15815719
[No Abstract] [Full Text] [Related]
32. Chromosomal translocations t(4;14), t(11;14) and proliferation rate stratify patients with mature plasma cell myelomas into groups with different survival probabilities: a molecular epidemiologic study on tissue microarrays.
Tinguely M; Jenni B; Reineke T; Korol D; Kofler A; Rousson V; Dommann-Scherrer C; Maurer R; Moch H; Probst-Hensch NM
Am J Surg Pathol; 2007 May; 31(5):690-6. PubMed ID: 17460451
[TBL] [Abstract][Full Text] [Related]
33. Cell cycle analysis and expression of cell cycle regulator genes in myeloma cells overexpressing cyclin D1.
Yata K; Sadahira Y; Otsuki T; Sakaguchi H; Isozaki Y; Uno M; Kurebayashi J; Fujii T; Eda S; Ueki A; Yawata Y; Yamada O; Sugihara T
Br J Haematol; 2001 Sep; 114(3):591-9. PubMed ID: 11552984
[TBL] [Abstract][Full Text] [Related]
34. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
Krämer A; Schultheis B; Bergmann J; Willer A; Hegenbart U; Ho AD; Goldschmidt H; Hehlmann R
Leukemia; 2002 Sep; 16(9):1844-51. PubMed ID: 12200702
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and clinical implications of t(11;14) in patients with amyloid light-chain amyloidosis with or without concurrent multiple myeloma.
Kobayashi H; Abe Y; Miura D; Narita K; Kitadate A; Takeuchi M; Matsue K
Jpn J Clin Oncol; 2019 Feb; 49(2):195-198. PubMed ID: 30608548
[TBL] [Abstract][Full Text] [Related]
36. Evidence of a role for activation of Wnt/beta-catenin signaling in the resistance of plasma cells to lenalidomide.
Bjorklund CC; Ma W; Wang ZQ; Davis RE; Kuhn DJ; Kornblau SM; Wang M; Shah JJ; Orlowski RZ
J Biol Chem; 2011 Apr; 286(13):11009-20. PubMed ID: 21189262
[TBL] [Abstract][Full Text] [Related]
37. MB4-2 breakpoint in MMSET combined with del(17p) defines a subset of t(4;14) multiple myeloma with very poor prognosis.
Lazareth A; Song XY; Coquin A; Harel S; Karlin L; Belhadj K; Roos-Weil D; Frenzel L; Tamburini J; Macro M; Chevret S; Loiseau HA; Minvielle S; Fermand JP; Soulier J; Bories JC; Arnulf B
Haematologica; 2015 Nov; 100(11):e471-4. PubMed ID: 26206803
[No Abstract] [Full Text] [Related]
38. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors.
Avet-Loiseau H; Gerson F; Magrangeas F; Minvielle S; Harousseau JL; Bataille R;
Blood; 2001 Nov; 98(10):3082-6. PubMed ID: 11698294
[TBL] [Abstract][Full Text] [Related]
39. Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels.
Specht K; Haralambieva E; Bink K; Kremer M; Mandl-Weber S; Koch I; Tomer R; Hofler H; Schuuring E; Kluin PM; Fend F; Quintanilla-Martinez L
Blood; 2004 Aug; 104(4):1120-6. PubMed ID: 15090460
[TBL] [Abstract][Full Text] [Related]
40. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
Fabris S; Agnelli L; Mattioli M; Baldini L; Ronchetti D; Morabito F; Verdelli D; Nobili L; Intini D; Callea V; Stelitano C; Lombardi L; Neri A
Genes Chromosomes Cancer; 2005 Feb; 42(2):117-27. PubMed ID: 15543617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
